ArticleFrontiers in oncology2026

The efficacy and safety of four different PD-1 checkpoint inhibitors in advanced non-small cell lung cancer: a real-world retrospective study.

Hanqi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.